Luigi Xerri

Chief Development Officer and VP of Business Development

Professional Overview
Luigi Xerri is an accomplished pharmaceutical executive with over 40 years of industry experience. As the Chief Development Officer and VP of Business Development at Venatorx Pharmaceuticals, Inc., he leverages his deep scientific expertise and strategic business acumen to drive the company's growth and development initiatives.

Experience Summary

Current Role
In his current role at Venatorx Pharmaceuticals, Luigi oversees all aspects of the company's product development pipeline, including clinical trial management, regulatory submissions, and commercialization strategies. He has played a pivotal role in securing key partnerships and licensing agreements, expanding Venatorx's reach and impact within the antibacterials market.

Career Progression
Luigi co-founded Venatorx Pharmaceuticals in 2008, serving as the company's Co-founder and Head of Scientific Affairs. Prior to this, he co-founded Protez Pharmaceutical, Inc., where he held the position of Co-founder and Chief Scientific Officer. Earlier in his career, Luigi spent nearly three decades at GlaxoSmithKline Pharmaceutical, where he rose through the ranks to become the Antibacterials Disease Strategy Head.

Academic Background
Luigi holds a strong academic background, with a focus on pharmaceutical sciences and drug development. His educational credentials include a degree in Pharmacy, as well as advanced training in Medicinal Chemistry and Pharmacology.

Areas of Expertise

• Antibacterial drug discovery and development

• Pharmaceutical business strategy and commercialization

• Scientific leadership and team management

• Regulatory affairs and clinical trial oversight

• Collaborative partnership and alliance management

Professional Impact
Throughout his career, Luigi has been responsible for numerous breakthroughs in the antibacterials field, including the development of several novel drug candidates that have advanced to late-stage clinical trials. His strategic vision and scientific acumen have been instrumental in shaping the growth and direction of the companies he has been associated with.

Conclusion
With his extensive industry experience, proven track record of success, and deep technical expertise, Luigi Xerri is a valuable asset to Venatorx Pharmaceuticals. His leadership and strategic guidance continue to drive the company's development efforts and position it as a key player in the fight against antibiotic-resistant infections.